VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 128 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 7.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,031,000 | +214.3% | 67,813 | +189.5% | 0.01% | +233.3% |
| Q1 2017 | $328,000 | -47.2% | 23,425 | -39.9% | 0.00% | -40.0% |
| Q4 2016 | $621,000 | -19.2% | 38,960 | -15.7% | 0.01% | -28.6% |
| Q3 2016 | $769,000 | +45.6% | 46,193 | 0.0% | 0.01% | +40.0% |
| Q2 2016 | $528,000 | +36.8% | 46,193 | 0.0% | 0.01% | +66.7% |
| Q1 2016 | $386,000 | -26.3% | 46,193 | -17.9% | 0.00% | -40.0% |
| Q4 2015 | $524,000 | -18.3% | 56,277 | -1.0% | 0.01% | -16.7% |
| Q3 2015 | $641,000 | +1263.8% | 56,868 | +1867.8% | 0.01% | – |
| Q2 2014 | $47,000 | – | 2,890 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |